Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice

Gene Therapy

Volumn 15, Issue 1, 2008, Pages 30-39

  Shen, F ^a,b   Fan, Y ^a   Su, H ^c   Zhu, Y ^a   Chen, Y ^a   Liu, W ^a   Young, W L ^a   Yang, G Y ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CIS ACTING ELEMENT; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; PARVOVIRUS VECTOR; SODIUM CHLORIDE; VASCULOTROPIN;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN BLOOD FLOW; BRAIN HEMANGIOMA; BRAIN ISCHEMIA; CELL PROLIFERATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DATA ANALYSIS; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; MOUSE STRAIN; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; TISSUE REPAIR; TUMOR GROWTH; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS STRAIN;

3' UNTRANSLATED REGIONS; ANIMALS; ANOXIA; ASTROCYTES; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DEPENDOVIRUS; ERYTHROPOIETIN; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NEURONS; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 37249078258     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303048     Document Type: Article

References (56)

1. Krupinski J, Kaluza J, Kumar P, Wang M, Kumar S. Prognostic value of blood vessel density in ischaemic stroke. Lancet 1993; 342: 742.
2. Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK et al. A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 1997; 28: 2518-2527.
3. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 2000; 31: 1863-1870.
4. Wang Y, Kilic E, Kilic U, Weber B, Bassetti CL, Marti HH et al. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 2005; 128: 52-63.
5. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111: 1843-1851.
6. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, Zhang Z et al. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after strpke in the rat. Circ Res 2003; 92: 308-313.
7. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001; 49: 507-521.
8. Hills CP. Ultrastructural changes in the capillary bed of the rat cerebral cortex in anoxic-ischemic brain lesions. Am J Pathol 1964; 44: 531-551.
9. Coyle P. Diameter and length changes in cerebral collaterals after middle cerebral artery occlusion in the young rat. Anat Rec 1984; 210: 357-364.
10. Coyle P, Heistad DD. Blood flow through cerebral collateral vessels one month after middle cerebral artery occlusion. Stroke 1987; 18 407-411.
11. Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994; 144: 188-199.
12. Sbarbati A, Pietra C, Baldassarri AM, Guerrini U, Ziviani L, Reggiani A et al. The microvascular system in ischemic cortical lesions. Acta Neuropathol (Berl) 1996; 92: 56-63.
13. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
14. Rosenstein JM, Mani N, Silverman WF, Krum JM. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95: 7086-7091.
15. Monahan PE, Samulski RJ. Adeno-associated virus vectors for gene therapy: More pros than cons? Mol Med Today 2000; 6: 433-440.
16. Zaiss AK, Liu Q, Bowen GP, Wong NC, Bartlett JS, Muruve DA. Differential activation of innate immune responses by adeno-virus and adeno-associated virus vectors. J Virol 2002; 76: 4580-4590.
17. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
18. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol Cell 1998; 2: 549-558.
19. Bohl D, Salvetti A, Moullier P, Heard JM. Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 1998; 92: 1512-1517.
20. Hofmann A, Nolan GP, Blau HM. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 1996; 93: 5185-5190.
21. Bohl D, Naffakh N, Heard JM. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med 1997; 3: 299-305.
22. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
23. Blau HM, Rossi FM. Tet B or not tet B: Advances in tetracycline-inducible gene expression. Proc Natl Acad Sci USA 1999; 96: 797-799.
24. Rossi FM, Guicherit OM, Spicher A, Kringstein AM, Fatyol K, Blakely BT et al. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet 1998; 20: 389-393.
25. Kringstein AM, Rossi FM, Hofmann A, Blau HM. Graded transcriptional response to different concentrations of a single transactivator. Proc Natl Acad Sci USA 1998; 95: 13670-13675.
26. 2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
27. Post DE, Van Meir EG. Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells. Gene Therapy 2001; 8: 1801-1807.
28. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci USA 2002; 99: 9480-9485.
29. Betz AL, Yang GY, Davidson BL. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 1995; 15: 547-551.
30. Parenti A, Bellik L, Brogelli L, Filippi S, Ledda F. Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2004; 286: H1978-H1984.
31. Laguens R, Cabeza Meckert P, Vera Janavel G, Del Valle H, Lascano E, Negroni J et al. Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer. Gene Therapy 2002; 9: 1676-1681.
32. Leker RR, Teichner A, Ovadia H, Keshet E, Reinherz E, Ben-Hur T. Expression of endothelial nitric oxide synthase in the ischemic penumbra: Relationship to expression of neuronal nitric oxide synthase and vascular enclothelial growth factor. Brain Res 2001; 909 1-7.
33. Cármeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
34. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 2000; 80: 99-115.
35. Cobbs CS, Chen J, Greenberg DA, Graham SH. Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat. Neurosci Lett 1998; 249: 79-82.
36. Hayashi T, Abe K, Suzuki H, Itoyama Y. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 1997; 28: 2039-2044.
37. Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M. VEGF and flt. Expression time kinetics in rat brain infarct. Stroke 1996; 27 1865-1872; discussion 1872-1863.
38. Lennmyr F, Ata KA, Funa K, Olsson Y, Terent A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 1998; 57: 874-882.
39. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusioh model of cerebral infarct. J Neuropathol Exp Neurol 1999; 58 654-666.
40. Jin KL, Mao XO, Qreenberg DA. Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia Proc Natl Acad Sci USA 2000; 97: 10242-10247.
41. Issa R, Krupinski J, Bujny T, Kumar S, Kaluza J, Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lap Invest 1999; 79: 417-425.
42. Lee OH, Kim YM, Lee YM, Moon EJ, Lee DJ, Kim JH et al. Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1999; 264: 743-750.
43. Tenenbaum L, Chtarto A, Lehtonon E, Velu T, Brotchi J, Levivier M. Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med 2004; 6 (Suppl 1): S212-S222.
44. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302-317.
45. Garcia JH, Kalimo H, Kamijyo Y, Trump BF. Cellular events during partial cerebral ischemia. I. Electron microscopy of feline cerebral cortex after middle-cerebral-artery occlusion. Virchows Arch B Cell Pathol 1977; 25: 191-206.
46. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin Invest 2000; 106: 829-838.
47. Schielke GP, Yang GY, Shivers BD, Betz AL. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 1998; 18: 180-185.
48. Ayata C, Dunn AK, Gursoy OY, Huang Z, Boas DA, Moskowitz MA. Laser speckle flowmetry for the study of cerebrovascular physiology in normal and ischemic mouse cortex. J Cereb Blood Flow Metab 2004; 24 744-755.
49. Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC. Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci USA 2007; 104: 2301-2306.
50. Zhu Y, Lawton MT, Du R, Shwe Y, Chen Y, Shen F et al. Expression of hypoxia-inducible factor-1 and vascular endothelial growth factor in response to venous hypertension. Neurosurgery 2006; 59: 687-696; discussion 687-696.
51. Kim CH, Cho YS, Chun YS, Park JW, Kim MS. Early expression of myocardial HIF-1alpha in response to mechanical stresses: Regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res 2002; 90: E25-E33.
52. Pufe T, Lemke A, Kurz B, Petersen W, Tillmann B, Grodzinsky AJ et al. Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol 2004; 164: 185-192.
53. Su H, Lu R, Kan YW. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci USA 2000; 97: 13801-13806.
54. Yang GY, Zhao Y, Davidson BL, Betz AL. Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res 1997; 751: 181-188.
55. Pang L, Ye W, Che XM, Roessler BJ, Betz AL, Yang GY. Reduction of inflammatory response in the mouse brain with adenoviral- mediated transforming growth factor-ss1 expression. Stroke 2001; 32: 544-552.
56. Yang GY, Chan PH, Chen J, Carlson E, Chan SF, Weinstein P et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 1994; 25: 165-170.